Table 1

TF/factor VII–initiated coagulation activation of saliva is associated with cell-derived vesicles from saliva

Monoclonal antibodySupernatantMicroparticlesExosomes
Saliva    
    None > 3600 283 ± 126 2202 ± 1251 
    FVII > 3600 > 3600 (P < .0001) > 3600 (P = .016) 
    FXII > 3600 270 ± 135 (P = .272) 1940 ± 1152 (P = .284) 
Plasma    
    None > 3600 2675 ± 849 > 3600 
    FVII > 3600 2838 ± 617 (P = .464) > 3600 
    FXII > 3600 2422 ± 660 (P = .403) > 3600 
Monoclonal antibodySupernatantMicroparticlesExosomes
Saliva    
    None > 3600 283 ± 126 2202 ± 1251 
    FVII > 3600 > 3600 (P < .0001) > 3600 (P = .016) 
    FXII > 3600 270 ± 135 (P = .272) 1940 ± 1152 (P = .284) 
Plasma    
    None > 3600 2675 ± 849 > 3600 
    FVII > 3600 2838 ± 617 (P = .464) > 3600 
    FXII > 3600 2422 ± 660 (P = .403) > 3600 

Saliva fractions (ie, isolated microparticles, exosomes, and vesicle-depleted saliva [Supernatant]) were tested for their ability to initiate clotting of autologous vesicle-depleted plasma, in the absence or presence of antibodies against factor VII or XII. For comparison, we also tested the ability of isolated fractions of microparticles and exosomes from plasma to initiate clotting (n = 7). Data are shown as clotting time (seconds).

or Create an Account

Close Modal
Close Modal